Callodine Capital Management, LP

Q4 2025 13F-HR Holdings

Location
Boston, MA
Holdings as of
12/31/2025
Date filed
2/13/2026
Form type
13F-HR
Num holdings
52
Total value ($000)
$1,245,095
Net value change ($000)
+103,560 (9.1%)
New positions
9
Sold out positions
10
Turnover %
17.9%
Sector allocation + QoQ delta (equities-only)
Prev filing: 11/13/2025 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q3 2025
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
VTRS 51,809 75.4%
SPB 31,926 35.4%
APO 23,198 53.3%
GSK 18,951 62.5%
LBRT 16,472 63.9%
GPN 15,402 52.4%
FCPT 11,519 61.7%
MRP 10,802 NEW
WFC 9,460 NEW
OWL 9,338 14.1%
Top Reduces (Value $000, Stocks/ETFs)
EQH -52,948 -100.0%
SNY -32,948 -100.0%
CVS -23,629 -100.0%
SEE -16,726 -100.0%
RGA -13,764 -100.0%
MTB -13,583 -100.0%
C -12,271 -100.0%
BRKR -10,872 -100.0%
WWW -10,158 -13.7%
BAX -9,195 -23.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type